A new study led by investigators from Mass General Brigham trialed stereotactic (targeted) brain-directed radiation in 100 patients with small cell lung cancer and brain metastases, finding they ...

A multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center has found that ...

For patients with newly diagnosed resectable brain metastases (BM), cesium-131 tile-based radiation therapy (TBRT), which ...

Progressive pulmonary fibrosis was independently associated with worse progression-free survival and overall survival.

Approach significantly improved local control, and longer survival observed in trial ...

Stereotactic radiation therapy has emerged as a cornerstone in the management of early-stage and locally recurrent non-small cell lung cancer (NSCLC), particularly in patients who are medically ...

Phase 3 ROADS enrolled 204 patients across 32 centers (2021–2025) with 2–7 cm brain metastases, comparing tile-based intraoperative radiation versus external stereotactic radiation. Surgical bed ...

For patients with brain metastases, treatment with an antibody-drug conjugate (ADC) at the same time as stereotactic radiotherapy significantly raises the risk of symptomatic radiation necrosis, a new ...

Stereotactic body radiation therapy (SBRT) has emerged as a precise, non-invasive modality for treating hepatocellular carcinoma (HCC), especially in patients unsuitable for resection or ablation. By ...

Please provide your email address to receive an email when new articles are posted on . Tile-based radiation therapy significantly improved recurrence and survival compared with stereotactic radiation ...

Impact of COVID-19 in Cervical and Breast Cancer Screening and Systemic Treatment in São Paulo, Brazil: An Interrupted Time Series Analysis The initial training plan was based on a needs assessment ...

SBRT combined with Nexavar improved median OS to 15.8 months versus 12.3 months with Nexavar alone in patients with advanced HCC. Median PFS increased from 5.5 months with Nexavar alone to 9.2 months ...